Cargando…
Genetic risk assessment towards warfarin application: Saudi Arabia study with a potential to predict and prevent side effects
Warfarin doses are greatly affected by polymorphism altering cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase complex subunit 1 (VKORC1) gene. This study evaluated the prevalence of alleles (either single or double) and carriers of single nucleotide polymorphisms (SNPs) in both genotypes...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933267/ https://www.ncbi.nlm.nih.gov/pubmed/31889870 http://dx.doi.org/10.1016/j.sjbs.2019.11.007 |